What is the recommended tapering schedule for discontinuing Lexapro (escitalopram) 20mg?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 3, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

How to Taper Lexapro 20mg

Taper Lexapro 20mg gradually over several months using a hyperbolic reduction schedule, decreasing by approximately 10% of the most recent dose every 2-4 weeks, reaching very small final doses (as low as 1-2mg) before complete discontinuation to minimize withdrawal symptoms.

Recommended Tapering Approach

Initial Tapering Phase

  • Reduce by 10% of the current dose every 2-4 weeks, not 10% of the original starting dose 1, 2, 3
  • From 20mg, the first reduction would be to 18mg (a 2mg decrease), then to approximately 16mg (another 2mg decrease from 18mg) 2, 3
  • The FDA label emphasizes gradual dose reduction rather than abrupt cessation whenever possible 1

Why Hyperbolic (Not Linear) Tapering

  • Linear tapering (reducing by the same mg amount each time) causes disproportionately large drops in serotonin transporter occupancy at lower doses, dramatically increasing withdrawal risk 2, 4
  • Hyperbolic tapering reduces the biological effect on serotonin transporters by equal amounts at each step, minimizing withdrawal symptoms 2, 3
  • Research demonstrates that reductions become progressively smaller in absolute mg amounts as the total dose decreases 2, 4

Slower Tapering at Lower Doses

  • Once reaching approximately 10mg or below, slow the taper further to 5% reductions of the most recent dose every 2-4 weeks 2, 3
  • Final doses before complete cessation may need to be as small as 1-2mg to prevent large decreases in receptor occupancy 2, 4
  • Studies show tapers over months (rather than the commonly recommended 2-4 weeks) demonstrate greater success in reducing withdrawal symptoms 2, 3

Critical Pitfalls to Avoid

Never Use Alternate-Day Dosing

  • Dosing every other day at any point during the taper causes severe fluctuations in receptor occupancy and significantly increases withdrawal risk 5
  • This applies even at minimum therapeutic doses or half-minimum doses 5
  • Escitalopram's pharmacokinetic profile makes it particularly unsuitable for alternate-day dosing strategies 5

Avoid Rapid Tapers

  • The commonly recommended 2-4 week tapers down to therapeutic minimum doses show minimal benefit over abrupt discontinuation 2
  • These short tapers are often not tolerated by patients and may be mistaken for relapse of the underlying condition 2

Monitoring and Management

Assess for Withdrawal Symptoms

  • Monitor for anxiety, insomnia, irritability, dizziness, nausea, and flu-like symptoms after each dose reduction 1, 2
  • If intolerable symptoms occur, return to the previous well-tolerated dose and slow the taper further 1, 2
  • Wait until symptoms resolve before attempting the next reduction 2, 3

Duration Considerations

  • Patients on escitalopram for longer durations (≥1 year) should taper even more slowly, potentially over 6-12 months or longer 2, 3
  • The risk of withdrawal symptoms increases with longer duration of previous therapy 2

Practical Implementation

Obtaining Flexible Doses

  • Liquid formulations allow for precise dose adjustments needed for hyperbolic tapering 3
  • Tapering strips (pre-packaged daily doses with gradual reductions) have shown 70-80% real-world effectiveness for antidepressant discontinuation 6
  • Compounding pharmacies can prepare custom doses for the final small reductions 3

Sample Hyperbolic Taper Schedule from 20mg

  • Week 0: 20mg daily
  • Week 2-4: 18mg daily (10% reduction)
  • Week 6-8: 16mg daily (11% reduction of 18mg)
  • Week 10-12: 14.5mg daily (9% reduction)
  • Week 14-16: 13mg daily (10% reduction)
  • Continue this pattern, with reductions becoming smaller in absolute mg amounts
  • Final weeks may involve reductions from 3mg to 2.5mg to 2mg to 1.5mg to 1mg before stopping 2, 4

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.